| Optimisation of growth hormone production by muscle cells using plasmid DNA. | |
| | |
MedLine Citation:
|
PMID: 10810297 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The production of peptide hormones by skeletal muscle tissue is a promising area of gene therapy. Skeletal muscle myogenesis can be induced in vitro, resulting in the fusion of mononucleate myoblasts to form multinucleate myotubes, and delivery vectors are first tested in vitro. C2C12 myoblasts transfected with pcDNA3-GH, which used the human cytomegalovirus (CMV) promoter, secreted immunoreactive GH with comparable biological activity to pituitary GH. Mouse myeloid leukaemia cells, which express the mouse GH receptor were used for the bioassay, and activation of these cells by GH was measured by a colorimetric microculture tetrazolium assay. Cells were incubated with a tetrazolium salt (MTS) and an intermediate electron acceptor (phenazine methosulphate, PMS), and formazan production was measured as optical density (O.D.) at 490 nm. The efficiencies of several plasmid expression vectors were compared in differentiated and non-differentiated muscle cells, as a function of bioactive GH secreted by the transfected cells. Ten-day differentiated C2C12 myotubes transfected with pcDNA3E-GH, which used the CMV promoter and a rat myosin light chain enhancer element, secreted significantly more biologically active GH than myotubes transfected with pcDNA3-GH (0.82 O.D. units+/-0.06 vs 0.57+/-0.05 respectively, P<0.001). This was consistent with reduced CMV promoter activity in myotubes. Myoblasts transfected with pcDNA3-GH secreted more bioactive GH than 10-day transfected myotubes (1.1+/-0. 1 vs 0.77+/-0.07 respectively). However, the responses were indistinguishable (both 1.0+/-0.09) if both the myotubes and myoblasts had been transfected with pcDNA3E-GH. Substitution of the vector pMHLC-GH, which used a muscle-specific truncated rabbit myosin heavy chain promoter, and the myosin enhancer resulted in a marked decrease in the responses to the conditioned medium from fused myotubes compared with the vectors pcDNA3-GH and pcDNA3E-GH (0. 24+/-0.02 vs 0.57+/-0.05 vs 0.82+/-0.06 respectively). We concluded that the combination of CMV promoter and myosin light chain enhancer in pcDNA3E-GH had the greatest expression efficiency of the several plasmid vectors which we investigated. |
| | |
Authors:
|
G S MacColl; F J Novo; N J Marshall; M Waters; G Goldspink; P M Bouloux |
Related Documents
:
|
1333317 - Tissue-specific expression of the skeletal alpha-actin gene involves sequences that can... 10514527 - Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in di... 7601117 - Autoregulation of actin synthesis in hepatocytes by transcriptional and posttranscripti... 8798647 - Differential expression of b-crystallin and hsp27 in skeletal muscle during continuous ... 10347107 - Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from po... 1311927 - Expression of the heparin-binding growth factor receptor genes in human megakaryocytic ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Journal of endocrinology Volume: 165 ISSN: 0022-0795 ISO Abbreviation: J. Endocrinol. Publication Date: 2000 May |
Date Detail:
|
Created Date: 2000-06-21 Completed Date: 2000-06-21 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0375363 Medline TA: J Endocrinol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 329-36 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Royal Free and University College Medical School, London, UK. gmaccoll@rfc.ucl.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Biological Assay / methods Blotting, Western Cells, Cultured Gene Therapy / methods* Genetic Vectors / administration & dosage* Growth Hormone / analysis, biosynthesis, genetics* Humans Mice Muscle, Skeletal / metabolism* Plasmids* Rabbits Rats Reverse Transcriptase Polymerase Chain Reaction / methods Transfection / methods* |
| Chemical | |
Reg. No./Substance:
|
9002-72-6/Growth Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies.
Next Document: Testosterone modulates growth hormone secretion at the hypothalamic but not at the hypophyseal level...